Newsletter Archive

51. 09.23.24 -- Nanoparticle Enabled Formulation And Drug Delivery Solutions 9/23/2024
    09/23/24 Advancing RNA Newsletter
52. 09.18.24 -- Two "Spicy" Takeaways On The FDA's Platform Designation Guidance 9/18/2024
    09/18/24 Advancing RNA Newsletter
53. 09.17.24 -- Outsourcing Strategies To Maximize RNA-LNP Success 9/17/2024

    09/17/24 Advancing RNA Newsletter

54. 09.12.24 -- Let's Deviate From Deviations - Sterile Drugs. 9/12/2024

    09/12/24 Advancing RNA Newsletter

55. 09.11.24 -- Is This The Hardest Question Facing mRNA Therapeutics Makers? 9/11/2024
    09/11/24 Advancing RNA Newsletter
56. 09.04.24 -- Why Bridge RNA Is Taking The RNA Space By Storm 9/4/2024
    09/04/24 Advancing RNA Newsletter
57. 08.28.24 -- The RNA Challenge Keeping RNA Execs Up At Night 8/28/2024
    08/28/24 Advancing RNA Newsletter
58. 08.26.24 -- Solutions For mRNA And Nanoparticle Manufacturing 8/26/2024
    08/26/24 Advancing RNA Newsletter
59. 08.21.24 -- Innovation Advances In mRNA Medicine 8/21/2024
    08/21/24 Advancing RNA Newsletter
60. 08.21.24 -- Simplifying Preclinical Development And Scale Up Of Lipid Nanoparticles 8/21/2024

    08/21/24 Advancing RNA Newsletter